Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126455831 | 12645583 | 1 | I | 20160802 | 20160811 | 20160811 | EXP | ES-JNJFOC-20160806595 | JANSSEN | LYDIA ABASOLO, ZULEMA ROSALES, DAVID DIAZ-VALLE, ALEJANDRO GOMEZ-GOMEZ, RAMYA C. PENA-BLANCO, ANGELA PRIETO-GARCIA, ET AL. IMMUNOSUPPRESSIVE DRUG DISCONTINUATION IN NONINFECTIOUS UVEITIS FROM REAL-LIFE CLINICAL PRACTICE: A SURVIVAL ANALYSIS. AMERICAN JOURNAL OF OPHTHALMOLOGY 01-SEP-2016;169:1-8. | 0.00 | Y | 0.00000 | 20160811 | MD | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126455831 | 12645583 | 1 | PS | GOLIMUMAB | GOLIMUMAB | 1 | Subcutaneous | U | 125289 | SOLUTION FOR INJECTION | |||||||||
| 126455831 | 12645583 | 2 | SS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | U | 103772 | LYOPHILIZED POWDER | |||||||||
| 126455831 | 12645583 | 3 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126455831 | 12645583 | 4 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126455831 | 12645583 | 5 | SS | AZATHIOPRINE. | AZATHIOPRINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126455831 | 12645583 | 6 | SS | ADALIMUMAB | ADALIMUMAB | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126455831 | 12645583 | 7 | SS | ETANERCEPT | ETANERCEPT | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126455831 | 12645583 | 8 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126455831 | 12645583 | 9 | SS | MYCOPHENOLATE | MYCOPHENOLIC ACID | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126455831 | 12645583 | 10 | SS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 126455831 | 12645583 | 11 | SS | TOCILIZUMAB | TOCILIZUMAB | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126455831 | 12645583 | 1 | Uveitis |
| 126455831 | 12645583 | 2 | Uveitis |
| 126455831 | 12645583 | 3 | Uveitis |
| 126455831 | 12645583 | 4 | Uveitis |
| 126455831 | 12645583 | 5 | Uveitis |
| 126455831 | 12645583 | 6 | Uveitis |
| 126455831 | 12645583 | 7 | Uveitis |
| 126455831 | 12645583 | 8 | Uveitis |
| 126455831 | 12645583 | 9 | Uveitis |
| 126455831 | 12645583 | 10 | Uveitis |
| 126455831 | 12645583 | 11 | Uveitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126455831 | 12645583 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126455831 | 12645583 | Adverse drug reaction | |
| 126455831 | 12645583 | Drug ineffective for unapproved indication | |
| 126455831 | 12645583 | Gastrointestinal disorder | |
| 126455831 | 12645583 | Hepatic enzyme increased | |
| 126455831 | 12645583 | Infection | |
| 126455831 | 12645583 | Off label use | |
| 126455831 | 12645583 | Renal impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |